These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 617858)

  • 1. [Human testing of the antigenic power of an avianized rabies vaccine].
    Tarsitani G; Mastroeni I; D'Arca Simonetti A; Vescia N; D'Arca SU
    Nuovi Ann Ig Microbiol; 1977; 28(5):279-87. PubMed ID: 617858
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunologic prevention of rabies. I. Experimental evaluation of the antigenic potency of an avianized vaccine].
    D'arca SU; Tarsitani G; Vescia N; Mastroeni I; D'arca Simonetti A
    Nuovi Ann Ig Microbiol; 1974; 25(4):229-39. PubMed ID: 4465762
    [No Abstract]   [Full Text] [Related]  

  • 3. Rabies postexposure prophylaxis with human diploid cell rabies vaccine: lower neutralizing antibody titers with Wyeth vaccine.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1985 Feb; 34(7):90-2. PubMed ID: 3918250
    [No Abstract]   [Full Text] [Related]  

  • 4. [Immunological prevention of rabies. II. Experimental evaluation of the antigenic potency of a phenolated vaccine of the Fermi type].
    Tarsitani G; Vescia N; Mastroeni I; D'Arca Simonetti A; D'Arca SU
    Nuovi Ann Ig Microbiol; 1974; 25(4):240-50. PubMed ID: 4465763
    [No Abstract]   [Full Text] [Related]  

  • 5. [Experience with new vaccines in active rabies vaccination of animals].
    Barth R; Jaeger O
    MMW Munch Med Wochenschr; 1978 Mar; 120(9):297-8. PubMed ID: 306060
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparison of PVRV and HDCV rabies vaccines as to immunity, reliability and protective value].
    Hacibektaşoğlu A; Inal A; Eyigün C; Barut A; Türkay FA
    Mikrobiyol Bul; 1992 Jan; 26(1):26-36. PubMed ID: 1574019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Determination of the specific activity of rabies vaccine by the degree of antibody sorption].
    Mad'iarova RS; Nikolaeva NV; Morogova VM; Gil'dina SS
    Vopr Virusol; 1973; 18(1):7-82. PubMed ID: 4791706
    [No Abstract]   [Full Text] [Related]  

  • 8. [Prevention of animal rabies by an attenuated monovalent or mixed vaccine].
    Soulebot JP; Précausta P; Brun A; Chappuis G; Terré J; Favre H; Petermann HG
    Dev Biol Stand; 1978; 41():389-99. PubMed ID: 753667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purified chick embryo cell (PCEC) rabies vaccine for human use: clinical trials.
    Bijok U; Vodopija I; Smerdel S; Thongcharoen P; Nicholson K; Dietrich M; Gonzalez de Cosio A
    Behring Inst Mitt; 1984 Nov; (76):155-64. PubMed ID: 6395850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human diploid cell strain vaccine for post-exposure rabies treatment.
    Sehgal S; Bhatia R; Bhardwaj M
    J Commun Dis; 1985 Mar; 17(1):87-91. PubMed ID: 4031447
    [No Abstract]   [Full Text] [Related]  

  • 11. [The Italian experience in the control of rabies. III. Laboratory studies on SADB19 Tü vaccine used in the fox vaccination campaign].
    Ciuchini F; Buonavoglia C
    Parassitologia; 1988; 30(1):35-47. PubMed ID: 3268771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results of vaccination of Asian elephants (Elephas maximus) with monovalent inactivated rabies vaccine.
    Isaza R; Davis RD; Moore SM; Briggs DJ
    Am J Vet Res; 2006 Nov; 67(11):1934-6. PubMed ID: 17078758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Rabies vaccine in Czechoslovakia. I. Hempt's vaccine and its modification].
    Slonim D; Stastný F; Brázdová AR
    Cesk Epidemiol Mikrobiol Imunol; 1982 Sep; 31(5):257-65. PubMed ID: 6215991
    [No Abstract]   [Full Text] [Related]  

  • 14. Antibody response after a two-year intradermal booster of rabies human diploid cell vaccine.
    Horman JT; Rullán JV; Myers RA; Bond JO; Israel E; Joseph JM
    J Am Vet Med Assoc; 1987 Jul; 191(2):185-7. PubMed ID: 3610792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody response to an anti-rabies vaccine in a dog population under field conditions in Bolivia.
    Suzuki K; González ET; Ascarrunz G; Loza A; Pérez M; Ruiz G; Rojas L; Mancilla K; Pereira JA; Guzman JA; Pecoraro MR
    Zoonoses Public Health; 2008 Oct; 55(8-10):414-20. PubMed ID: 18399941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rabies antibody titers in vaccinees: protection, failure and prospects.
    Dutta JK; Pradhan SC; Dutta TK
    Int J Clin Pharmacol Ther Toxicol; 1992 Mar; 30(3):107-12. PubMed ID: 1506120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pilot study on intradermal vaccination of Japanese rabies vaccine for pre-exposure immunization.
    Shiota S; Khawplod P; Ahmed K; Mifune K; Nishizono A
    Vaccine; 2008 Nov; 26(50):6441-4. PubMed ID: 18804510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simulated post-exposure rabies vaccination with purified chick embryo cell vaccine using a modified Thai Red Cross regimen.
    Madhusudana SN; Sanjay TV; Mahendra BJ; Suja MS
    Int J Infect Dis; 2004 May; 8(3):175-9. PubMed ID: 15109593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rabies antibody seroprotection rates among travelers in Nepal: "rabies seroprotection in travelers".
    Ranney M; Partridge R; Jay GD; Rozzoli DE; Pandey P
    J Travel Med; 2006; 13(6):329-33. PubMed ID: 17107424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Investigation of antibody levels following rabies vaccination in the subjects who were biten by animals].
    Baysal B; Tosun S; Ozdemir M; Doğan M
    Mikrobiyol Bul; 2009 Jan; 43(1):127-31. PubMed ID: 19334389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.